LAUFLUMIDE AND DERIVATIVES THEREOF FOR TREATING CHRONIC FATIGUE SYNDROME AND MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME (ME/CFS)

The invention concerns a compound of formula (I), wherein R1 = halogen atom selected in the group consisting of: F, Cl, Br, I, and R2 = H or OH, or a pharmaceutically acceptable isomer, salt and/or solvate thereof, for use in preventing and/or treating chronic fatigue syndrome.